Treatment of whole blood with riboflavin and uv light: Impact on malaria parasite viability and whole blood storage

Shock

Volumn 44, Issue , 2015, Pages 33-38

  Owusu Ofori, Shirley ^a   Kusi, Joseph ^a   Owusu Ofori, Alex ^b   Freimanis, Graham ^a   Olver, Christine ^c   Martinez, Caitlyn R ^c   Wilkinson, Shilo ^d   Mundt, Janna M ^d   Keil, Shawn D ^d   Goodrich, Raymond P ^d   Allain, Jean Pierre ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^c Department of Environmental and Radiological Health Sciences   (United States)

^d Terumo BCT Inc   (United States)

Author keywords

Cold storage; Pathogen reduction; Sub saharan Africa; Whole blood

Indexed keywords

RIBOFLAVIN; HEMOGLOBIN;

ADULT; AMPLICON; ARTICLE; BLOOD SAFETY; BLOOD STORAGE; CELL VIABILITY; CRYOPRESERVATION; FEMALE; GENE AMPLIFICATION; HUMAN; IN VITRO STUDY; LIMIT OF QUANTITATION; MALE; PARASITEMIA; PLASMODIUM; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; PROCEDURES; QUANTITATIVE ANALYSIS; ULTRAVIOLET RADIATION; ADOLESCENT; AFRICA SOUTH OF THE SAHARA; ANEMIA; BLOOD; BLOOD BANK; BLOOD TRANSFUSION; COMMUNICABLE DISEASE CONTROL; DRUG EFFECTS; MALARIA; MIDDLE AGED; PARASITOLOGY; RADIATION RESPONSE; TEMPERATURE;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; ANEMIA; BLOOD BANKS; BLOOD SAFETY; BLOOD TRANSFUSION; COMMUNICABLE DISEASE CONTROL; FEMALE; HEMOGLOBINS; HUMANS; MALARIA; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; RIBOFLAVIN; TEMPERATURE; ULTRAVIOLET RAYS;

EID: 84912141075     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000280     Document Type: Article

References (28)

1. Freimanis G, Sedegah M, Owusu-Ofori S, Kumar S, Allain JP: Investigating the prevalence of transfusion transmission of Plasmodium within a hyperendemic blood donation system. Transfusion 53(7):1429-41, 2013.
2. Owusu-Ofori AK, Betson M, Parry CM, Stothard JR, Bates I: Transfusiontransmitted malaria in Ghana. Clin Infect Dis 56(12):1735-1741, 2013.
3. Owusu-Ofori AK, Parry C, Bates I: Transfusion-Transmitted malaria in countries where malaria is endemic: A review of the literature from Sub-Saharan Africa. Clin Infect Dis 51(10):1192-1198, 2010.
4. Reddy HL, Dayan AD, Cavagnaro J, Gad S, Li J, Goodrich RP: Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation. Transfus Med Rev 22(2):133-153, 2008.
5. Mundt JM, Rouse L, Van den Bossche J, Goodrich RP: Chemical and Biological Mechanisms of Pathogen Reduction Technologies. Photochem Photobiol 90(5):957-964, 2014.
6. Goodrich RP, Doane S, Reddy HL: Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products. Biologicals 38(1):20-30, 2010.
7. Fast LD, Nevola M, Tavares J, Reddy HL, Goodrich RP, Marschner S: Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-Associated graft-versus-host disease? Transfusion 53(2):373-81, 2013.
8. Tonnetti L, Thorp AM, Reddy HL, Keil SD, Goodrich RP, Leiby DA: Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood. Transfusion 52(2):409Y416, 2012.
9. Tonnetti L, Thorp AM, Reddy HL, Keil SD, Goodrich RP, Leiby DA: Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood. Transfusion 53(4):860-867, 2013.
10. El Chaar M, Atwal S, Freimanis GL, Dinko B, Sutherland CJ, Allain JP: Inactivation of Plasmodium falciparum in whole blood by riboflavin plus irradiation. Transfusion 53(12):3174-3183, 2013.
11. Marschner S, Goodrich R: Pathogen reduction technology treatment of platelets, plasma and whole blood using riboflavin and UV light. Transfus Med Hemother 38:8-18, 2011.
12. Keil S, Rapaport R, Doane S, Young R, Marschner S, Campbell T: Viral reduction of intracellular HIV using the Mirasol system for whole blood [poster abstract]. Vox Sang 103:68-271, 2012.
13. Rougemont M, Van SM, Sahli R, Hinrikson HP, Bille J, Jaton K: Detection of four Plasmodium species in blood from humans by 18S rRNA gene subunitbased and species-specific real-Time PCR assays. J Clin Microbiol 42(12): 5636-5643, 2004.
14. Singh B, Bobogare A, Cox-Singh J, Snounou G, Abdullah MS, Rahman HA: A genus-And species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. Am J Trop Med Hyg 60(4):687-692, 1999.
15. Ala F, Allain JP, Bates I, Boukef K, Boulton F, Brandful J, Dax EM, El EM, Farrugia A, Gorlin J, et al.: External financial aid to blood transfusion services in Sub-Saharan Africa: A need for reflection. Plos Med 9(9):e1001309, 2012.
16. Bakkour S, Chafets DM, Wen L, van der Meer PF, Mundt JM, Marschner S, Goodrich RP, Busch MP, Lee TH: Development of a mitochondrial DNA realtime polymerase chain reaction assay for quality control of pathogen reduction with riboflavin and ultraviolet light. Vox Sang 107(4):351-359, 2014.
17. Aytay S, Ohagen A, Busch MR, Alford B, Chapman JR, Lazo A: Development of a sensitive PCR inhibition method to demonstrate HBV nucleic acid inactivation. Transfusion 44(4):476-484, 2004.
18. Allain JP, Hsu J, Pranmeth M, Hanson D, Stassinopoulos A, Fischetti L, Corash L, Lin L: Quantification of viral inactivation by photochemical treatment with amotosalen and UV A light, using a novel polymerase chain reaction inhibition method with preamplification. J Infect Dis 194(12):1737-1744, 2006.
19. Sawyer L, Hanson D, Castro G, Luckett W, Dubensky TW Jr, Stassinopoulos A: Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination. Transfusion 47(6):1062-1070, 2007.
20. Pidcoke H, McFaul S, Ramasubramanian A, Parida B, Mora A, Fedyk C, Valdez-Delgado K, Montgomery R, Reddoch K, Rodriguez A, et al.: Primary hemostatic capacity of whole blood: A comprehensive analysis of pathogen reduction and refrigeration effects over time. Transfusion 53Suppl 1:137S-13749S, 2013.
21. Latham JT Jr, Bove JR, Weirich FL: Chemical and hematologic changes in stored CPDA-1 blood. Transfusion 22(2):158-159, 1982.
22. Burger P, Korsten H, Verhoeven AJ, de Korte D, van BR: Collection and storage of red blood cells with anticoagulant and additive solution with a physiologic pH. Transfusion 52(6):1245-1252, 2012.
23. Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain A, Nelson KE, Bowman S, et al.: Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419(6906):498-511, 2002.
24. Okoye O, Reddy H, Wong M, Doane S, Resnick S, Karamanos E: Large animal evaluation of the safety and efficacy of whole blood treated with the Mirasol System in a diffuse, non-surgical bleeding model. Transfusion 53(Suppl 1): 82A, 2013.
25. Reddy H, Doane S, Keil S, Marschner S, Goodrich R: Development of a riboflavin and ultraviolet light-based device to treat whole blood. Transfusion 53(Supp 1):131S-136S, 2013.
26. Parpart AK, Gregg JR, Lorenz PB, Parpart ER, Chase AM: Whole blood preservation; a problem in general physiology. An in vitro analysis of the problem of blood storage. J Clin Invest 26(4):641-654, 1947.
27. Cancelas JA, Rugg N, Fletcher D, Pratt PG, Worsham DN, Dunn SK, Marschner S, Reddy HL, Goodrich RP: In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet lightYtreated whole blood. Transfusion 51(7):1460-1468, 2011.
28. Allain J, Owusu-Ofori S, Bates I: Blood transfusion in Sub-Saharan Africa. TATM 6:16Y23, 2004.